Companies / Santa Cruz Biotechnology / CD5 (UCH-T2) FITC
Santa Cruz Biotechnology

CD5 (UCH-T2) FITC | Santa Cruz Biotechnology

mouse monoclonal IgG1; CD5 Antibody (UCH-T2) is an IgG1 κ mouse monoclonal CD5 antibody (also designated CD5 antibody) that detects the CD5 protein of mouse, rat and human origin by WB, IP, IF, IHC(P) and FCM. CD5 Antibody (UCH-T2) is available as both the non-conjugated anti-CD5 antibody form, as well as multiple conjugated forms of anti-CD5 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. CD5 (also designated Lyt-1) has been identified as a transmembrane glycoprotein that is expressed on 70% of normal peripheral blood lymphocytes and on virtually all T lymphocytes in thymus and peripheral blood. Activation of T cells through the T cell receptor (TCR) results in tyrosine phosphorylation of CD5, and the absence of CD5 renders T cells hyper-responsive to TCR-mediated activation. CD5 associates with the TCR/ CD3-z chain and with the Src family kinase Lck p56. In vitro studies have shown a 10- to 15-fold increase in the kinase activity of Lck bound to CD5. The B cell antigen, CD72, serves as a receptor for CD5. The consequence of CD5 binding to its cognate receptor is still in question and likely plays a role in thymic selection.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.